Panel Discussion: How can biotechs best leverage partnerships early on in drug development to ensure cancer vaccine success?

Time: 11:45 am
day: Day Two


  • Assessing the importance of bringing in the right staff from the field
  • Developing the science and the story in early development to attract potential
    partners, when you don’t have clinical data available
  • Attributes of a perfect partnership
  • Types of partnerships (in/out licensing of product, financing of clinical trial,
    providing comparator drug, etc.)
  • Key partnerships crucial at different timepoints
  • Evidence from the field where effective partnerships have resulted in key